These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29339019)

  • 1. Immuno-modulatory functions of the type-3 secretion system and impacts on the pulmonary host defense: A role for ExoS of Pseudomonas aeruginosa in cystic fibrosis.
    Belmadi N; Wu Y; Touqui L
    Toxicon; 2018 Mar; 143():68-73. PubMed ID: 29339019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ADP-ribosyltransferase domain of the effector protein ExoS inhibits phagocytosis of Pseudomonas aeruginosa during pneumonia.
    Rangel SM; Logan LK; Hauser AR
    mBio; 2014 Jun; 5(3):e01080-14. PubMed ID: 24917597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed with cystic fibrosis following newborn screening.
    Hu H; Harmer C; Anuj S; Wainwright CE; Manos J; Cheney J; Harbour C; Zablotska I; Turnbull L; Whitchurch CB; Grimwood K; Rose B;
    Clin Microbiol Infect; 2013 Mar; 19(3):266-72. PubMed ID: 22329595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serodiagnosis of Pseudomonas aeruginosa infections in mucoviscidosis: comparative study of Western blotting, ELISA exotoxin A and ELISA phospholipase C].
    Fournier C; Andre J; Marlier H; Guinet R; Gilly R
    Pathol Biol (Paris); 1993 Nov; 41(9):856-64. PubMed ID: 8121717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activities of Pseudomonas aeruginosa effectors secreted by the Type III secretion system in vitro and during infection.
    Lee VT; Smith RS; Tümmler B; Lory S
    Infect Immun; 2005 Mar; 73(3):1695-705. PubMed ID: 15731070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Children with cystic fibrosis produce an immune response against exoenzyme S, a type III cytotoxin of Pseudomonas aeruginosa.
    Banwart B; Splaingard ML; Farrell PM; Rock MJ; Havens PL; Moss J; Ehrmantraut ME; Frank DW; Barbieri JT
    J Infect Dis; 2002 Jan; 185(2):269-70. PubMed ID: 11807706
    [No Abstract]   [Full Text] [Related]  

  • 7. [Infections of the respiratory tract with Pseudomonas aeruginosa in cystic fibrosis].
    Winkler U; Wingender J; Jäger KE
    Klin Wochenschr; 1985 Jun; 63(11):490-8. PubMed ID: 3925219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptors in the host defense against Pseudomonas aeruginosa respiratory infection and cystic fibrosis.
    McIsaac SM; Stadnyk AW; Lin TJ
    J Leukoc Biol; 2012 Nov; 92(5):977-85. PubMed ID: 22892106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type III apparatus of Pseudomonas aeruginosa as a tool to diagnose pulmonary infection in cystic fibrosis patients.
    Cruz AC; Neves BC; Higa LY; Folescu T; Marques EA; Milagres LG
    APMIS; 2012 Aug; 120(8):622-7. PubMed ID: 22779684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reaction of antibody in sera from cystic fibrosis patients with non-toxic forms of Pseudomonas aeruginosa exotoxin A.
    Klinger KW; Shuster CW; Klinger J
    Eur J Clin Microbiol; 1985 Apr; 4(2):201-6. PubMed ID: 3924609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exotoxin S secreted by internalized Pseudomonas aeruginosa delays lytic host cell death.
    Kroken AR; Gajenthra Kumar N; Yahr TL; Smith BE; Nieto V; Horneman H; Evans DJ; Fleiszig SMJ
    PLoS Pathog; 2022 Feb; 18(2):e1010306. PubMed ID: 35130333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomonas aeruginosa Effector ExoS Inhibits ROS Production in Human Neutrophils.
    Vareechon C; Zmina SE; Karmakar M; Pearlman E; Rietsch A
    Cell Host Microbe; 2017 May; 21(5):611-618.e5. PubMed ID: 28494242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis.
    Hollsing AE; Granström M; Vasil ML; Wretlind B; Strandvik B
    J Clin Microbiol; 1987 Oct; 25(10):1868-74. PubMed ID: 3117842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa infection in cystic fibrosis. Relationship between mucoid strains of Pseudomonas aeruginosa and the humoral immune response.
    Hoiby N
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Aug; 82(4):551-8. PubMed ID: 4213330
    [No Abstract]   [Full Text] [Related]  

  • 15. Biology of Pseudomonas aeruginosa in relation to pulmonary infection in cystic fibrosis.
    Pitt TL
    J R Soc Med; 1986; 79 Suppl 12(Suppl 12):13-8. PubMed ID: 2425090
    [No Abstract]   [Full Text] [Related]  

  • 16. Type III secretion phenotypes of Pseudomonas aeruginosa strains change during infection of individuals with cystic fibrosis.
    Jain M; Ramirez D; Seshadri R; Cullina JF; Powers CA; Schulert GS; Bar-Meir M; Sullivan CL; McColley SA; Hauser AR
    J Clin Microbiol; 2004 Nov; 42(11):5229-37. PubMed ID: 15528719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early immune response to the components of the type III system of Pseudomonas aeruginosa in children with cystic fibrosis.
    Corech R; Rao A; Laxova A; Moss J; Rock MJ; Li Z; Kosorok MR; Splaingard ML; Farrell PM; Barbieri JT
    J Clin Microbiol; 2005 Aug; 43(8):3956-62. PubMed ID: 16081936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of loop-mediated isothermal amplification assays for genotyping of Type III Secretion System in Pseudomonas aeruginosa.
    Shi H; Chen Z; Kan J
    Lett Appl Microbiol; 2015 Oct; 61(4):361-6. PubMed ID: 26219625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Inhibitors of Pseudomonas aeruginosa Exotoxin-S ADP-Ribosyltransferase Activity.
    Pinto AF; Ebrahimi M; Saleeb M; Forsberg Å; Elofsson M; Schüler H
    J Biomol Screen; 2016 Jul; 21(6):590-5. PubMed ID: 26850638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Pseudomonas aeruginosa exotoxin A a good carrier protein for conjugate vaccines?
    Pier GB
    Hum Vaccin; 2007; 3(2):39-40; author reply 41. PubMed ID: 17268204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.